Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 947-402-0 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Effects on fertility
Description of key information
NOAEL was considered to be 300 mg/kg/day for P generation when Wistar male and female rat were treated with test chemical orally by gavage for 63 days.
Thus, the test chemical is not likely to be toxic as per the criteria mentioned in CLP regulation.
Link to relevant study records
- Endpoint:
- screening for reproductive / developmental toxicity
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Reliability:
- 4 (not assignable)
- Rationale for reliability incl. deficiencies:
- secondary literature
- Justification for type of information:
- Data is form BASF Corporation
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 422 (Combined Repeated Dose Toxicity Study with the Reproduction / Developmental Toxicity Screening Test)
- Principles of method if other than guideline:
- Combined Repeated Dose Toxicity Study with the Reproduction/Developmental Toxicity Screening Test in Wistar Rats treated with test chemical
- GLP compliance:
- not specified
- Limit test:
- no
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Route of administration:
- oral: gavage
- Type of inhalation exposure (if applicable):
- not specified
- Vehicle:
- not specified
- Details on exposure:
- not specified
- Details on mating procedure:
- - M/F ratio per cage:1: 1 ratio - Length of cohabitation:Overnight - Proof of pregnancy: [vaginal plug / sperm in vaginal smear] referred to as [day 0 / day 1] of pregnancyThe day on which sperm was detected was referred to as gestation day (GD) 0 and the following day as GD 1.
- Analytical verification of doses or concentrations:
- not specified
- Duration of treatment / exposure:
- More than 63 days
- Frequency of treatment:
- Daily
- Details on study schedule:
- not specified
- Dose / conc.:
- 0 mg/kg bw/day (actual dose received)
- Dose / conc.:
- 100 mg/kg bw/day (actual dose received)
- Dose / conc.:
- 300 mg/kg bw/day (actual dose received)
- Dose / conc.:
- 1 000 mg/kg bw/day (actual dose received)
- No. of animals per sex per dose:
- not specified
- Control animals:
- yes, concurrent vehicle
- Details on study design:
- not specified
- Positive control:
- not specified
- Parental animals: Observations and examinations:
- Survival, Clinical sign, Hemoglobin and clinical chemistry were examined.
- Oestrous cyclicity (parental animals):
- Not specified
- Sperm parameters (parental animals):
- Not specified
- Litter observations:
- Not specified
- Postmortem examinations (parental animals):
- Gross pathology and histopathology was examined.
- Postmortem examinations (offspring):
- Not specified
- Statistics:
- Not specified
- Reproductive indices:
- Not specified
- Offspring viability indices:
- Not specified
- Clinical signs:
- not specified
- Dermal irritation (if dermal study):
- not specified
- Mortality:
- not specified
- Body weight and weight changes:
- not specified
- Food consumption and compound intake (if feeding study):
- not specified
- Food efficiency:
- not specified
- Water consumption and compound intake (if drinking water study):
- not specified
- Ophthalmological findings:
- not specified
- Haematological findings:
- not specified
- Clinical biochemistry findings:
- effects observed, treatment-related
- Description (incidence and severity):
- When treated with 1000 mg/kg/day, Increased creatinine levels were observed in male and female rats and Increased urea and potassium levels in female rats were observed.
- Urinalysis findings:
- not specified
- Behaviour (functional findings):
- not specified
- Immunological findings:
- not specified
- Organ weight findings including organ / body weight ratios:
- not specified
- Histopathological findings: non-neoplastic:
- effects observed, treatment-related
- Description (incidence and severity):
- Minimally increased occurrence of single cell necrosis or apoptosis in the liver of six males and three females at 1000 mg/kg/day
- Histopathological findings: neoplastic:
- not specified
- Other effects:
- not specified
- Reproductive function: oestrous cycle:
- not specified
- Reproductive function: sperm measures:
- not specified
- Reproductive performance:
- not specified
- Dose descriptor:
- NOAEL
- Effect level:
- 300 mg/kg bw/day (actual dose received)
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- haematology
- histopathology: non-neoplastic
- Remarks on result:
- other: No effect observed
- Critical effects observed:
- not specified
- System:
- other: not specified
- Organ:
- not specified
- Treatment related:
- not specified
- Dose response relationship:
- not specified
- Relevant for humans:
- not specified
- Clinical signs:
- not specified
- Dermal irritation (if dermal study):
- not specified
- Mortality / viability:
- not specified
- Body weight and weight changes:
- not specified
- Food consumption and compound intake (if feeding study):
- not specified
- Food efficiency:
- not specified
- Water consumption and compound intake (if drinking water study):
- not specified
- Ophthalmological findings:
- not specified
- Haematological findings:
- not specified
- Clinical biochemistry findings:
- not specified
- Urinalysis findings:
- not specified
- Sexual maturation:
- not specified
- Organ weight findings including organ / body weight ratios:
- not specified
- Gross pathological findings:
- not specified
- Histopathological findings:
- not specified
- Other effects:
- not specified
- Behaviour (functional findings):
- not specified
- Developmental immunotoxicity:
- not specified
- Dose descriptor:
- other: not specified
- Generation:
- other: not specified
- Based on:
- not specified
- Sex:
- not specified
- Basis for effect level:
- other: not specified
- Remarks on result:
- other: not specified
- Critical effects observed:
- not specified
- System:
- other: not specified
- Organ:
- not specified
- Treatment related:
- not specified
- Dose response relationship:
- not specified
- Relevant for humans:
- not specified
- Reproductive effects observed:
- not specified
- Treatment related:
- not specified
- Relation to other toxic effects:
- not specified
- Dose response relationship:
- not specified
- Relevant for humans:
- not specified
- Conclusions:
- NOAEL was considered to be 300 mg/kg/day for P generation when Wistar male and female rat were treated with test chemical orally by gavage for 63 days.
- Executive summary:
In a Combined Repeated Dose Toxicity Study with the Reproduction/Developmental Toxicity Screening Test, Westar male and female rat were treated with test chemical in the concentration of 0, 100, 300 and 1000 mg/kg bw/day orally by gavage for 63 days. Increased creatinine levels were observed in male and female rats and increased urea and potassium levels in female rats were observed at 1000 mg/kg/day. In addition, minimal increased occurrence of single cell necrosis or apoptosis in the liver of six males and three females at 1000 mg/kg/day. No effect at 100 and 300 mg/kg bw was observed. NOAEL was considered to be 300 mg/kg/day for P generation when Wistar male and female rat were treated with test chemical orally by gavage for 63 days.
Reference
Effect on fertility: via oral route
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- NOAEL
- 300 mg/kg bw/day
- Study duration:
- subchronic
- Species:
- rat
- Quality of whole database:
- Data is Klimisch 4 and from secondary source
Effect on fertility: via inhalation route
- Endpoint conclusion:
- no study available
Effect on fertility: via dermal route
- Endpoint conclusion:
- no study available
Additional information
Reproductive toxicity:
Studies available for the test chemicals was reviewed to determine the toxic nature of[2-[[2-cyano-3-[ 4-( diethylam ino) phenyl]-1-oxoallyl]oxy]ethyl][3-[[2-cyano-3-[ 4-( diethylamino )phenyl]-1-oxoallyl]oxy]propyl]dimethylammon ium chloride.The studies are as mentioned below:
Study 1
In a Combined Repeated Dose Toxicity Study with the Reproduction/Developmental Toxicity Screening Test, Westar male and female rat were treated with test chemical in the concentration of 0, 100, 300 and 1000 mg/kg bw/day orally by gavage for 63 days. Increased creatinine levels were observed in male and female rats and increased urea and potassium levels in female rats were observed at 1000 mg/kg/day. In addition, minimal increased occurrence of single cell necrosis or apoptosis in the liver of six males and three females at 1000 mg/kg/day. No effect at 100 and 300 mg/kg bw was observed. Therefore, NOAEL was considered to be 300 mg/kg/day for P generation when Wistar male and female rat were treated with test chemical orally by gavage for 63 days.
Study 2
In a Reproductive/Teratogenic toxicity study Dutch Belted female Rabbits were treated with test chemical in the concentration of 0, 30, 100 and 250 mg/kg body weight/day by oral gavage. One rabbits died each in 30 and 250 mg/kg bw/day including control. One rabbit aborted on day 28 of gestation at 250 mg/kg bw/day as compared to control. Pneumonia was observed in three rabbit which were died. Orange discoloration of the urine was observed in all the treated rabbits between days 7 and 28 of gestation as compared to control. No effect on body weight and body weight gain and No effect on Post-implantation loss/dam, Total implantations/dam and Corpora lutea/dam were observed in treated rabbits as compared to control. Similarly, there were no biologically meaningful or statistically significant differences in the number of litters, Foetal sex and gross pathological changes were observed in treated rabbits as compared to control. In addition, No effect on viability of foetus, foetal body weight and sex of foetus were observed as compared to control. At 30 and 100 mg/kg be/day, malformations were observed in two foetuses from two litters. However, these values fell within the ranges of historical control data. There were no biologically meaningful or statistically significant differences in number of fetuses with malformations, number of foetuses or litters with developmental variations were observed in foetuses of any of the treated groups. Therefore, Reproductive NOAEL was considered to be 250 mg/kg body weight /day for F0 and F1 generation when Dutch Belted female rabbits were treated with test chemical orally by gavage from day 6 to 27 of gestation.
Study 3
In a Repeated Dose Toxicity Study Newly weaned albino male and female rats treated with test chemical in the concentration of 0, 200, 1000 and 2000 mg/kg/day orally in feed for 90 days. All animals were died at 5th week of study at 5000 mg/kg bw. Except for one female which succumbed in the 9thweek. No mortality was observed in 200 and 1000 mg/kg bw treated rats. All animals looked very sick in the second week of the experiment at 5000 mg/kg bw. No abnormalities in appearance were observed in 200 and 1000 mg/kg bw treated rats. Decrease in body weight were observed in treated rats at 1000 and 5000 mg/kg bw as compared to control. Slight decrease in body weight but not significant as compared to control from week 6 onwards at 200 mg/kg bw. Decrease in food consumption were observed in treated rats at 5000 mg/kg bw and slight decrease in food consumption were observed in treated rats at 200 and 1000 mg/kg bw as compared to control. Decrease in food efficiency were observed in treated rats at 5000 mg/kg bw and slight decrease in food efficiency were observed in treated rats at 1000 mg/kg bw as compared to control. Decrease in food efficiency were observed in treated rats at 200 mg/kg bw as compared to control. Similarly, significant increase in percentage of neutrophils and White blood cell counts were observed in treated male and female rats at 1000 mg/kg bw and significant increase in Packed cell volume were observed in male rats at 200 mg/kg bw but no dose-relationship was observed. Increase in SGOT activity of females and decreased in SAP activity of males were observed at 1000 mg/kg bw, decreased SGOT activity in males at 200 mg/kg bw but not observed at 1000 mg/kg bw and is therefore considered incidental. Slight decrease in G6Pase activity with increasing levels of Tinopal was observed in females only. When the enzyme activity is expressed per unit body weight the figures show a slight tendency to increase with increasing levels of Tinopal in males, while in females there are no distinct differences between the groups. Very slight decrease in G6PD enzyme activity with increasing levels of Tinopal in females. Here, too, this decrease disappeared when the enzyme activity was expressed per unit body weight. In addition, increase in relative weights of the kidney, liver and the brain and decrease in testis and ovary weight were observed at 1000 mg/kg bw as compared to control. No effect on reproductive organ weight of 200 mg/kg bw treated male and female rats were observed as compared to control. Large, pale kidneys in all male and female rats at 1000 mg/kg bw. Most of the male rats in this group had strikingly small testicles, other les ions noted at autopsy, such as unilateral hydronephrocis, eurly signs of murine pneuronia, and proteinaceous plugs in urinary bladder, are frequently encountered in the strain of used rats. They may therefore, not be related to the ingestion of the test compound. Necrosis, swelling, irregular vacuolization (Sudan III negative) and granular deterioration (eosinophylic, PAS-negative granules) of tubular epithelial cells in the renal cortex of all male and felllll1e rats at 1000 mg/kg bw. Sloughed necrotic tubular material was often found in tubular lumens. The nuclei of viable tubulur cells varied considerably in size and chromatin content. Dilated tubules lined by flattened epithelium and filled with proteinaceous casts were seen in most animals. Moderate degree of bilateral testicular atrophy were observed in male rats at 1000 mg/kg bw. A number of seminiferous tubules only contained Sertoli cells and occasional spermatogonia containing an irregularly vacuolated cytoplasm, Partial inhibition of spermatogenosis occurred in other tubules in which many polynucleated giant cells were seen. Varying numbers of seminiferous tubules still showed a normal development of sperm cells. In the epididymic tubules cellular debris, scattered spermatozoa and a few giant cells were found. Therefore, NOAEL was considered to be 200 mg/kg/day for P generation when Newly weaned albino male and female rats treated with test chemical orally by feed for 90 days.
Based on the data available for the target test chemical and read across chemicals,[2-[[2-cyano-3-[ 4-( diethylam ino) phenyl]-1-oxoallyl]oxy]ethyl][3-[[2-cyano-3-[ 4-( diethylamino )phenyl]-1-oxoallyl]oxy]propyl]dimethylammon ium chlorideis considered to be safe at dose 300 mg/Kg/day. Hence the test chemical is not likely to be toxic as per the criteria mentioned in CLP regulation.
Effects on developmental toxicity
Effect on developmental toxicity: via oral route
- Endpoint conclusion:
- no study available
Effect on developmental toxicity: via inhalation route
- Endpoint conclusion:
- no study available
Effect on developmental toxicity: via dermal route
- Endpoint conclusion:
- no study available
Justification for classification or non-classification
Based on the data available for the target test chemical and read across chemicals,[2-[[2-cyano-3-[ 4-( diethylam ino) phenyl]-1-oxoallyl]oxy]ethyl][3-[[2-cyano-3-[ 4-( diethylamino )phenyl]-1-oxoallyl]oxy]propyl]dimethylammon ium chlorideis considered to be safe at dose 300 mg/Kg/day. Hence the test chemical is not likely to be toxic as per the criteria mentioned in CLP regulation.
Additional information
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.